The cancer pathways, proteoglycans in the tumor microenvironment, EGFR tyrosine kinase pathway, and PI3K-Akt signaling pathway may correlate with the therapeutic effect of TSAC in treating breast cancer. Here, AKT1 is linked to breast carcinoma.